Ozempic maker Novo Nordisk said that while the European Union faces intermittent shortages of the diabetes drug in the final quarter of 2024 due to strong demand, the problem will not affect all member states https://t.co/YHfkHErDPC pic.twitter.com/u3wAm6VsAC
— Reuters (@Reuters) September 4, 2024
Categories